Search alternatives:
systemic decrease » systemic disease (Expand Search), systemic diseases (Expand Search)
mean decrease » a decrease (Expand Search)
ns decrease » nn decrease (Expand Search), a decrease (Expand Search), we decrease (Expand Search)
_ systemic » _ systematic (Expand Search)
50 ns » 50 ms (Expand Search)
systemic decrease » systemic disease (Expand Search), systemic diseases (Expand Search)
mean decrease » a decrease (Expand Search)
ns decrease » nn decrease (Expand Search), a decrease (Expand Search), we decrease (Expand Search)
_ systemic » _ systematic (Expand Search)
50 ns » 50 ms (Expand Search)
-
1
-
2
-
3
-
4
Molecular dynamics simulations of the three systems (PPARG-MOL000098, PPARG-MOL000354, PPARG-MOL000422) after 50 ns.
Published 2025Subjects: “…treatments remarkably decreased…”
-
5
Molecular dynamics simulations of the three systems (TNF-MOL000098, TNF-MOL000354, TNF-MOL000422) after 50 ns.
Published 2025Subjects: “…treatments remarkably decreased…”
-
6
-
7
The decrease or inhibition of Hsp90 induced REST degradation.
Published 2019“…(D) The level of REST dramatically reduced in differentiated SH-SY5Y cells treated with GA (1 μM) or PU-H71 (50 nM) at 24 h. (E) The REST level decreased by GA more than 50% and (F) PU-H71 more than 80%, respectively. …”
-
8
Molecular dynamics simulations of the three systems (MMP9-MOL000098, MMP9-MOL000354, MMP9-MOL000422) after 50 ns.
Published 2025Subjects: “…treatments remarkably decreased…”
-
9
Molecular dynamics simulations of the three systems (IL-6-MOL000098, IL-6-MOL000354, IL-6-MOL000422) after 50 ns.
Published 2025Subjects: “…treatments remarkably decreased…”
-
10
-
11
-
12
HFD induces LDs and decreases ER and mitochondria in nephrocytes.
Published 2021“…(<b>E</b>) Low and high magnification views of pericardial nephrocytes (dotted outlines) from STD and HFD larvae, showing that HFD decreases mitochondria (marked with anti-ATP5A) and ER (marked with anti-KDEL) but increases LDs (marked with LipidTOX). …”
-
13
-
14
-
15
SLE decreases risk for hormonal cancers.
Published 2021“…(b) Prostate cancer incidence in male SLE cohort is significantly decreased by SLE status (OR 0.23, 95% CI 0.089, 0.50, p = 0.0053).…”
-
16
-
17
-
18
-
19
-
20